| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 06/12/2013 | CN103145590A Clean L-arginine production technology |
| 06/12/2013 | CN103145589A Synthesis method of phenylguanidine bicarbonate |
| 06/12/2013 | CN102083897B Method of making ligand functionalized substrates |
| 06/12/2013 | CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof |
| 06/05/2013 | CN103130637A Ibuprofen-arginine and preparation method thereof |
| 06/05/2013 | CN103130595A Method for hydrolyzing feather to extract amino acid through microwave heating at high temperature and high pressure |
| 06/05/2013 | CN102659639B Preparation technology of leonurine |
| 06/05/2013 | CN102241555B Method for preparing photoactived amino acid through resolution |
| 05/30/2013 | US20130137706 Antimicrobial Molecules For Treating Multi-Drug Resistant and Extensively Drug Resistant Strains Of Mycobacterium |
| 05/29/2013 | CN102030685B Anti-beta-farnesene analog containing guanidine or nitro-ethylene as well as preparation method and applications thereof |
| 05/29/2013 | CN101289485B Absorption of nucleic acids to solid phases under low-salt conditions |
| 05/15/2013 | CN103108861A Neuraminidase inhibitors |
| 05/14/2013 | CA2419469C Derivatives of peptides and peptide mimetics having integrin inhibitor properties ii |
| 05/08/2013 | EP2588550A1 Curable polysiloxane coating composition |
| 05/08/2013 | EP2588537A1 Curable-on-demand composition comprising dual reactive silane functionality |
| 05/08/2013 | EP2588536A1 Curable-on-demand polysiloxane coating composition |
| 05/08/2013 | CN103086926A Preparation method for leonurine and derivatives thereof |
| 05/02/2013 | WO2013060889A1 Compounds for the treatment of influenza |
| 05/02/2013 | US20130105745 Aminoguanidinephenylphosphinate flame retardant compositions |
| 05/02/2013 | CA2853715A1 Compounds for the treatment of influenza |
| 05/01/2013 | CN101511781B Method for preparing hexa-methylene bi-cyanoguanidines and chlorhexidine |
| 04/25/2013 | WO2013022280A3 N1-cyclic amine-n2-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 04/25/2013 | WO2013022279A3 N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 04/25/2013 | WO2013022278A3 N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 04/25/2013 | DE102011085136A1 Use of new or known guanidine compound or a mixture comprising of two or more guanidine compounds e.g. as flavoring agent for creating, mediating, modifying and/or amplifying a salty flavor impression of sodium chloride |
| 04/24/2013 | EP2582354A2 Amino acid derivatives; compositions containing them; use as agents for treating human perspiration |
| 04/24/2013 | CN103059009A 4-nitro-3-(5-tetrazole) furoxan energetic ionic salt and preparation method thereof |
| 04/24/2013 | CN103058890A Method for preparing guanfacine hydrochloride |
| 04/24/2013 | CN103058889A Production method of guanidinium thiocyanate |
| 04/24/2013 | CN101208297B Antiviral compounds and methods |
| 04/23/2013 | CA2542206C Method for synthesis of acrylamide derivatives |
| 04/18/2013 | WO2013053726A1 Phenyl-guanidine derivatives |
| 04/18/2013 | US20130096193 Creatine beta-alaninate: a novel salt for increasing athletic performance |
| 04/18/2013 | US20130095140 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 04/18/2013 | CA2851205A1 Phenyl-guanidine derivatives |
| 04/17/2013 | EP2581367A2 Salts of isophosphoramide mustard and analogs thereof |
| 04/10/2013 | CN103030569A Preparation method of safflower pollen amino acids |
| 04/10/2013 | CN102274736B Application of aluminum chloride in catalyzing amine and carbodiimide addition reaction |
| 04/04/2013 | WO2013047372A1 Method for producing polypeptide fragment with high efficiency, which is suitable for ncl method |
| 04/04/2013 | CA2849752A1 Method for producing polypeptide fragment with high efficiency, which is suitable for ncl method |
| 04/03/2013 | CN103012214A Method for preparing nafamostat hydrochloride and nafamostat mesylate |
| 04/03/2013 | CN103012213A Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
| 04/03/2013 | CN102161619B Ferulic acid Jiangtang compound salt as well as preparation method and application thereof |
| 03/28/2013 | WO2013042082A1 Novel compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | CA2849309A1 Novel compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications |
| 03/27/2013 | EP2573069A2 Inhibitors of histone deacetylase and prodrugs thereof |
| 03/27/2013 | CN102993057A Synthesis method of 1,6-bis(cyano-guanidino) hexane |
| 03/27/2013 | CN102993056A Preparation method of chlorhexidine compound |
| 03/27/2013 | CN102993055A Polymorphic substance of guanfacine hydrochloride and preparation method thereof |
| 03/27/2013 | CN102992997A New medical salt of dexibuprofen |
| 03/26/2013 | US8404893 Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 03/26/2013 | CA2643994C Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins |
| 03/21/2013 | WO2013039187A1 Guanidinobenzoic acid compound |
| 03/21/2013 | US20130071439 Methods and compositions for treating biofilms |
| 03/21/2013 | CA2848561A1 Guanidinobenzoic acid compound |
| 03/20/2013 | CN102985503A Curable composition comprising dual reactive silane functionality |
| 03/20/2013 | CN102976978A Preparation method of L-arginine ethyl ester hydrochloride |
| 03/14/2013 | WO2013035102A1 Processes for the preparation of imatinib base and intermediates thereof |
| 03/14/2013 | WO2013034756A1 Biphenyl compounds for use in treating malaria and other parasitic disorders |
| 03/14/2013 | US20130065965 Di(4-chloro-phenyldiguanido) derivative which is free of potential genotoxicity and a process for reducing the residual amount of p-chloroaniline in said di(4-chloro-phenyldiguanido) derivative |
| 03/13/2013 | CN1938244B Fluoridation method |
| 03/13/2013 | CN102971381A Curable-on-demand polysiloxane coating composition |
| 03/13/2013 | CN102971380A Curable-on-demand composition comprising dual reactive silane functionality |
| 03/13/2013 | CN102964267A Cyclohexene compound having influenza virus neuraminidase inhibition activity, preparation method and application |
| 03/13/2013 | CN102964239A Metallo-beta-lactamase inhibitor |
| 03/07/2013 | US20130059929 Microbiologically stable, easily applicable preparations |
| 03/07/2013 | US20130059914 Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof |
| 03/06/2013 | CN102959024A Curable polysiloxane coating composition |
| 03/06/2013 | CN102952077A Preparation method and performance calculation for 2-(dinitromethyl)-3-nitro-1,3-diazacyclo-pent-1-ene ionic salt containing energy |
| 03/06/2013 | CN102952033A Novel compound, composing method thereof and therapeutic use therefor |
| 03/06/2013 | CN101142175B Peptidic compounds |
| 03/05/2013 | US8389768 Methods and compositions comprising novel cationic lipids |
| 03/05/2013 | US8389740 Process for preparing ionic liquids by anion exchange |
| 02/27/2013 | EP2560486A1 Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof |
| 02/27/2013 | CN102942589A Salts of isophosphoramide mustard and analogs thereof |
| 02/27/2013 | CN102940891A Lipids, lipid complexes and use thereof |
| 02/21/2013 | US20130046092 Switchable solvents and methods of use thereof |
| 02/20/2013 | CN102936211A Method for continuously producing dicyandiamide |
| 02/14/2013 | WO2013022280A2 N1-cyclic amine-n2-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 02/14/2013 | WO2013022279A2 N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 02/14/2013 | WO2013022278A2 N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 02/14/2013 | WO2013021355A1 Functionalized calixarene derivatives for cell transfection |
| 02/14/2013 | US20130040388 Cytostatic drug composition |
| 02/13/2013 | CN102924338A Production technology of nitroguanidine |
| 02/13/2013 | CN102924337A Production process of guanidine nitrate |
| 02/07/2013 | US20130035509 Novel Use of the Guanidinium Cation and Light-Emitting Component |
| 02/06/2013 | EP2552885A1 Neuraminidase inhibitors |
| 02/06/2013 | CN102911071A Super-molecule complex containing amino acid and water-solubility pillar [5] arene and preparation method for complex |
| 01/30/2013 | CN101786962B Method for producing amino acid chelate iron |
| 01/24/2013 | US20130023585 Neuraminidase Inhibitors |
| 01/23/2013 | CN202682830U Dicyandiamide crystallizing pot cooling device |
| 01/23/2013 | CN102887838A Preparation method of guanfacine hydrochloride |
| 01/23/2013 | CN102887837A Method for producing arginine |
| 01/22/2013 | US8357722 Lipids, lipid complexes and use thereof |
| 01/17/2013 | US20130018194 Octahydrobinaphthol derivative for l/d optical conversion and optical resolution |
| 01/16/2013 | CN102875420A L-arginine compound crystal and preparation method thereof |
| 01/16/2013 | CN101717352B Method for synthesizing agmatine sulfate |
| 01/09/2013 | EP2542889A1 Ligand guanidinyl functionalized polymers |
| 01/09/2013 | CN102863359A Synthesis method of anti-flu medicine |